Clin2
NCT06720662Possibly a fitNot yet recruiting

Fish oil pill to lower heart risk in people with heart disease

Atherosclerosis Cardiovascular Disease

Part of Heart & circulation clinical trials.

This trial tests whether a prescription fish oil pill (icosapent ethyl) can further lower the risk of heart problems in people who already have heart disease and are taking a statin. It may help if your cholesterol and inflammation levels are in a certain range.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
294 people
Ages
45 years and older
Study type
Interventional

Who can take part

  • You are 45 or older.
  • You have been diagnosed with heart or blood vessel disease.
  • You take a statin (with or without ezetimibe) at the same dose for at least 4 weeks.
  • Your blood tests show: C-reactive protein (a marker of inflammation) between 1 and 4.5, triglycerides (blood fats) between 150 and 500, HDL ("good" cholesterol) between 30 and 50, and LDL ("bad" cholesterol) between 40 and 100.
  • If you are a woman who could become pregnant, you are not pregnant, not breastfeeding, not planning pregnancy, and using birth control.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07641257Not yet recruiting
Icosapent Ethyl Effects on Heart Disease and Inflammation

This study tests whether a medication called icosapent ethyl (a purified fish oil) can help reduce plaque buildup in heart arteries and lower inflammation in people with heart disease. Researchers will use imaging and blood tests to see if it protects your heart.

NCT06731400Not yet recruiting
Fatty acids in blood and fish oil study

This study looks at how fatty acids in your blood differ based on health status. You will take a fish oil supplement, and researchers will measure changes in your blood over time.

NCT07762755Not yet recruiting· Phase 4
Study of icosapent ethyl for high-risk heart plaque

This study tests a medication called icosapent ethyl (a type of fish oil) to see if it can reduce inflammation in dangerous heart plaques. It might help prevent heart attacks or strokes in people with certain high-risk plaque features.

Beijing, Beijing Municipality
NCT07331103Recruiting
Can a special diet reduce inflammation for heart health?

This study tests whether a special diet can reduce inflammation and improve heart health in people over 55 who are at increased risk for heart disease but have not yet had a heart attack or stroke.

Avellino, AV
NCT06494488Recruiting· Early Phase 1
Testing how omega-3s affect heart health and blood clotting

This study tests whether two types of omega-3s (EPA and DHA) help improve HDL (good cholesterol) and reduce blood clot risk in people with high triglycerides and low HDL cholesterol.

Providence, Rhode Island
NCT06172335Recruiting
Testing fish oil for heart health in people with belly fat

This study tests whether a type of fish oil can help reduce plaque buildup in arteries, focusing on people with high triglycerides and extra belly fat.

Oslo

Hear when a new Atherosclerosis Cardiovascular Disease trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.